Glioma

A Combined Preclinical Therapy of Cannabinoids and Temozolomide against Glioma
Antitumor Effects of Cannabidiol, a Nonpsychoactive Cannabinoid, on Human Glioma Cell Lines
Cannabidiol, a Non-Psychoactive Cannabinoid Compound, Inhibits Proliferation and Invasion in U87-MG and T98G Glioma Cells through a Multitarget Effect
Cannabidiol inhibits human glioma cell migration through a cannabinoid receptor-independent mechanism
Cannabinoid action induces autophagy-mediated cell death through stimulation of ER stress in human glioma cells
Cannabinoids Inhibit Glioma Cell Invasion by Down-regulating Matrix Metalloproteinase-2 Expression
Cannabinoids Inhibit the Vascular Endothelial Growth Factor Pathway in Gliomas
Δ9-Tetrahydrocannabinol induces apoptosis in C6 glioma cells
Inhibition of Glioma Growth in Vivo by Selective Activation of the CB2 Cannabinoid Receptor

For general inquiries:

845-988-HEMP

[email protected]

Questions about your order?

[email protected]

Want to learn more and try Fusion CBD for free?

Let’s grow together #fusionfam

© 2017 - 2020 Fusion Holding Group. All Rights Reserved.

Disclaimer: The statements made regarding these products have not been evaluated by the Food and Drug Administration. The efficacy of these products has not been confirmed by FDA-approved research. These products are not intended to diagnose, treat, cure or prevent any disease. All information presented here is not meant as a substitute for or alternative to information from health care practitioners. Please consult your health care professional about potential interactions or other possible complications before using any product. The Federal Food, Drug and Cosmetic Act requires this notice.